Research map: Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia

Back to the article

Papers in this map

  1. Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer · Karim S. Fizazi · 2017 · 2313 citations · Cited by this paper
  2. Long-term experience with emicizumab in people with hemophilia A in the Canadian Bleeding Disorders Registry · 2026 · Related
  3. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL · Michael J. Hallek · 2018 · 1755 citations · Cited by this paper
  4. Chronic GVHD Consortium CATCH Study: Incidence, initial presentation and risk factors for chronic GVHD development · 2026 · Related
  5. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions · Kirsten Fischer · 2019 · 876 citations · Cited by this paper
  6. Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q · 2026 · Related
  7. Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center · Yucai Wang · 2019 · 136 citations · Cited by this paper
  8. Reframing Hematologic and Thrombovascular Care for Transgender and Gender-Diverse Individuals: A Scoping Review · 2026 · Related
  9. First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial · Moritz Fürstenau · 2024 · 84 citations · Cited by this paper
  10. Frequency, kinetics, and clinical significance of HHV-6 DNAemia after PTCy-based hematopoietic cell transplant · 2026 · Related
  11. Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA · Mazyar S. Shadman · 2024 · 65 citations · Cited by this paper
  12. Optimizing outcomes and accessibility of matched sibling donor transplant for transfusion dependent thalassemia in LMICs · 2026 · Related
  13. Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed · Anushka Walia · 2023 · 61 citations · Cited by this paper
  14. The zebrafish model tackles anti-P2Y12 variability in humans: a translational approach · 2026 · Related
  15. Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia · Othman Al‐Sawaf · 2025 · 52 citations · Cited by this paper
  16. A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia · 2026 · Related
  17. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL · Jennifer Ann Woyach · 2024 · 50 citations · Cited by this paper
  18. In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway · 2026 · Related
  19. Outcomes after biochemical or clinical progression in patients with multiple myeloma · Sarah Goldman‐Mazur · 2022 · 30 citations · Cited by this paper
  20. JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation · 2026 · Related
  21. Early progression of disease as a predictor of survival in chronic lymphocytic leukemia · Inhye E. Ahn · 2017 · 14 citations · Cited by this paper
  22. Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL) · Othman Al‐Sawaf · 2019 · 7 citations · Cited by this paper
  23. Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful? · Daniel S. Childs · 2024 · 3 citations · Cited by this paper
  24. Redefining early vs late progressive disease (PD) in chronic lymphocytic leukemia: A pooled analysis of fixed-duration therapies · Florian Simon · 2025 · 2 citations · Cited by this paper
  25. Progression of disease within 36 months (POD36) of starting first-line targeted therapy independently predicts poor overall survival in patients with chronic lymphocytic leukemia (CLL) · Paul Joseph Hampel · 2025 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)